A single arm phase II study to individualise dasatinib dosing based on trough levels and molecular response to maintain efficacy whilst minimising toxicity

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/16/RAH/217
NMA SSA Reference Number: SSA/31915/MonH-2018-152468
Monash Health Ref: RES-18-0000-604X
StatusActive
Effective start/end date17/10/1816/10/23